Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CEAMSA is a Spanish specialty ingredients company focused on the production, development, and global distribution of natural hydrocolloids derived from seaweed and other natural sources. Its portfolio includes carrageenan, pectin, fiber, alginate, and locust bean gum used primarily in food and beverage applications, with additional exposure to pharmaceutical and nutraceutical formulations. The company appears to operate as a commercial-stage manufacturer rather than a drug developer, supplying functional ingredients that provide stabilizing, gelling, thickening, and texturizing properties. Founded in 1966 and headquartered in O Porriño, Galicia, CEAMSA has built an international business with manufacturing capabilities and a strong export orientation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CEAMSA.